Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

12.60
Delayed Data
As of Mar 24
 +0.05 / +0.40%
Today’s Change
6.31
Today|||52-Week Range
13.70
+3.70%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close12.55
Today’s open12.60
Day’s range12.50 - 13.20
Volume413,121
Average volume (3 months)328,269
Market cap$525.8M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-730.77%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratio32.3
Price/Sales4.86
Price/Book5.43

Competitors

 Today’s
change
Today’s
% change
SPPISpectrum Pharmaceuti...+0.07+0.99%
ACHNAchillion Pharmaceut...-0.03-0.79%
OMEROmeros Corp+0.20+1.76%
SCLNSciClone Pharmaceuti...+0.15+1.56%
Data as of 4:14pm ET, 03/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs